Alan Levy - Intuitive Surgical Insider

ISRG -- USA Stock  

USD 532.02  23.80  4.68%

  Director
Dr. Alan J. Levy, Ph.D. is Lead Independent Director of the Company. Dr. Levy was the Founder, Chairman and Chief Executive Officer of Chrono Therapeutics, a privatelyheld digital medicine company, from February 2014 to February 2018. From 2012 to 2017, he was a Senior Advisor at Frazier Healthcare Ventures, and also a Venture Partner from 2007 to 2012. From June 2010 to January 2013, he was the Chief Executive Officer of Incline Therapeutics, Inc., a novel drugdevice company that was acquired by the Medicines Company in 2013. He served as Chairman of the Board of Directors of Northstar Neuroscience, Inc., a medical device company he cofounded, from 2007 to 2009. Prior to that, he was the President and Chief Executive Officer of Northstar Neuroscience from 1999 to 2007. From 1993 to 1998, Dr. Levy served as President and Chief Executive Officer of Heartstream, Inc., a medical device company that was acquired by HewlettPackard in 1998. Prior to joining Heartstream, Inc., he was President of Heart Technology, Inc., a medical device company that was acquired by Boston Scientific in 1995. Before joining Heart Technology, Dr. Levy was Vice President of Research and New Business Development and a member of the Board of Directors of Ethicon, a division of Johnson Johnson. Dr. Levy holds a B.S. in Chemistry from City University of New York and a Ph.D. in Organic Chemistry from Purdue University. Dr. Levy currently serves as a director of several private companies and notforprofit organizations.
Age: 79  Director Since 2013      
408-523-2100  http://www.intuitivesurgical.com

Alan Levy Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 12.52 % which means that it generated profit of $12.52 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 15.36 % meaning that it created $15.36 on every $100 dollars invested by stockholders.

Similar Executives

Showing few of many executives

DIRECTOR Since

William KozyThe Cooper Companies
2016
Mark DikerCantel Medical Corp
2007
Guido NeelsEndologix
2010
Thomas ZentyEndologix
2013
Cathy SmithBaxter International
2017
Wayne HockmeyerBaxter International
2007
Claire FraserBecton Dickinson and Company
2006
Jonathan FeldschuhDaxor Corporation
2017
Craig SwandalBovie Medical Corporation
2018
Eric NortonCantel Medical Corp
2016
Edward DeGraanBecton Dickinson and Company
2003
Stanley SternEkso Bionics Holdings
2014
Albert StrouckenBaxter International
2004
James GavinBaxter International
2003
John AndresBovie Medical Corporation
2014
Alan BatkinCantel Medical Corp
2004
Steven RosenbergThe Cooper Companies
1993
Laura ForeseCantel Medical Corp
2015
Michael MahoneyBaxter International
2015
Ronnie MyersCantel Medical Corp
2016
Robert AbernathyHaemonetics Corporation
2017

Entity Summary

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company was founded in 1995 and is headquartered in Sunnyvale, California. Intuitive Surgical operates under Medical Instruments Supplies classification in USA and is traded on BATS Exchange. It employs 4444 people.Intuitive Surgical (ISRG) is traded on BATS Exchange in USA. It is located in CALIFORNIA U.S.A and employs 4,444 people. Intuitive Surgical is listed under Medical Equipment category by Fama And French industry classification.

Intuitive Surgical Leadership Team

David Rosa, Chief Commercial Officer and Executive VP
Mark Rubash, Independent Director
Michael Friedman, Director
Jamie Samath, Principal Accounting Officer, VP and Corporate Controller
Amal Johnson, Independent Director
Craig Barratt, Independent Director
Eric Halvorson, Independent Director
Lonnie Smith, Chairman and Executive Officer
Jami Nachtsheim, Independent Director
Gary Guthart, CEO and President and Director
Alan Levy, Independent Director
Don Kania, Director
Myriam Curet, Senior Vice President Chief Medical Officer
Mark Meltzer, Chief Compliance Officer, Sr. VP and General Counsel
Colin Morales, Senior Vice President - Manufacturing and Service Operations
Salvatore Brogna, Executive VP of Product Operations
George Stalk, Independent Director
Keith Leonard, Director
Marshall Mohr, CFO and Sr. VP

Stock Performance Indicators

Did you try this?

Run Portfolio Rebalancing Now

   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Portfolio Rebalancing

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Search macroaxis.com